Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05225038 · ClinicalTrials.gov registry record · NA
Multidimensional Prehabilitation in Pancreatic Surgery for Pancreatic and Periampullary Neoplasms
A NA study of Pancreatic Neoplasms and Periampullary Carcinoma, sponsored by Case Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
- 1
- Study location
NCT05225038: Completed NA study of Pancreatic Neoplasms and Periampullary Carcinoma, sponsored by Case Comprehensive Cancer Center.
NCT05225038 is a NA study of Pancreatic Neoplasms and Periampullary Carcinoma that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 23 participants, below the 601-participant average among 30 other Pancreatic Neoplasms trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05225038, a NA study of Pancreatic Neoplasms and Periampullary Carcinoma, has completed, sponsored by Case Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
- 1
- Study location
Study Summary
Randomized Clinical Trial Investigating Multidimensional Prehabilitation in Pancreatic Surgery for participants with Pancreatic and Periampullary Neoplasms
Primary Outcome
Previous studies have demonstrated that grip strength is a predictor of surgical outcomes and mortality in cancer participants. Grip strength will be measured utilizing the Jamar Dynamometer.
Conditions Studied
Interventions
- OTHER Exercise
- BEHAVIORAL Smoking Cessation
- DIETARY_SUPPLEMENT Nutritional
- BEHAVIORAL Behavioral Medicine
Study Locations (1)
Ohio
- Cleveland Clinic Taussig Cancer Center, Case Comprehensive Cancer Center - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2022-06-13 |
| Est. Completion | 2023-10-30 |
| Phase | NA |
What the finished NCT05225038 record still lists
NCT05225038 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 601-participant average among 30 other Pancreatic Neoplasms trials with a reported enrollment target (96% lower).
The record links to 2 conditions, with Pancreatic Neoplasms appearing as the primary indexed condition, and to 4 interventions - of which Exercise is the first listed.
NCT05225038 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT05225038 about?
NCT05225038 is a clinical study titled "Multidimensional Prehabilitation in Pancreatic Surgery for Pancreatic and Periampullary Neoplasms". Randomized Clinical Trial Investigating Multidimensional Prehabilitation in Pancreatic Surgery for participants with Pancreatic and Periampullary Neoplasms
What is the current status of trial NCT05225038?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2022-06-13. Estimated completion is 2023-10-30.
What conditions does trial NCT05225038 study?
This clinical trial studies the following conditions: Pancreatic Neoplasms, Periampullary Carcinoma.
What interventions are being tested in trial NCT05225038?
The interventions under investigation include: Exercise (OTHER), Smoking Cessation (BEHAVIORAL), Nutritional (DIETARY_SUPPLEMENT), Behavioral Medicine (BEHAVIORAL).
Who is sponsoring clinical trial NCT05225038?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05225038 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pancreatic Neoplasms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05225038's enrollment target sits among peer trials
23 26th of 30 higher than 5 of 30 other Pancreatic Neoplasms trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pancreatic Neoplasms trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Trial Comparing EUS-guided Radiofrequency Ablation vs. EUS-guided Celiac Plexus Neurolysis
COMPLETED · NA
-
Respiratory-gated Stereotactic Body Radiation Therapy for Adenocarcinoma of the Pancreas or Periampullary Region
COMPLETED · NA
-
A Pancreatic Cancer Screening Study in Individuals With New-Onset or Deteriorating Diabetes Mellitus
RECRUITING
-
Determining Individualized Cancer Therapy in Pancreatic Cancer
RECRUITING
-
Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer
RECRUITING · Phase 2
-
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI